Filing Details
- Accession Number:
- 0001214659-24-018499
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-06 17:05:55
- Reporting Period:
- 2024-11-04
- Accepted Time:
- 2024-11-06 17:05:55
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1581280 | Twist Bioscience Corp | TWST | Biological Products, (No Disgnostic Substances) (2836) | 462058888 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1755970 | John Patrick Finn | C/O Twist Bioscience Corporation 681 Gateway Blvd. South San Francisco CA 94080 | President And Coo | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-11-04 | 30,000 | $0.00 | 189,483 | No | 4 | A | Direct | |
Common Stock | Acquisiton | 2024-11-04 | 27,287 | $0.00 | 216,770 | No | 4 | A | Direct | |
Common Stock | Acquisiton | 2024-11-04 | 23,551 | $0.00 | 240,321 | No | 4 | A | Direct | |
Common Stock | Disposition | 2024-11-04 | 2,681 | $41.56 | 237,640 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | A | Direct | |
No | 4 | A | Direct | |
No | 4 | S | Direct |
Footnotes
- Represents performance stock units for which target criteria was determined to have been met on November 4, 2024. 60% of the PSUs remain subject to time-based vesting and will vest on October 1,2025, subject to continued service or acceleration of vesting as provided in the award agreement.
- Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.